Overview
This study investigates if head and neck squamous cell carcinoma can be tracked with cell-free tumor DNA, RNA or HPV-DNA, in blood samples from patients referred with suspicion of cancer, and if it can be used in detecting recurrence in patients already diagnosed and treated for head and neck squamous cell carcinoma.
Eligibility
Inclusion Criteria:
- Patients 18 years old or older
- Suspicion of head and neck cancer
Exclusion Criteria:
- Diagnosed with cancer within the last 3 years ( apart from basal cell carcinoma)
- Diagnosed with an inflammatory or haematological disease after the age of 18
- Received chemotherapy or immunosuppressive treatment within the last 3 years
- Underwent a FNA ( fine-needle aspiration biopsy) or a biopsy from the head and neck region within 1 week.